Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 2, 2005 - Issue 1
Submit an article Journal homepage
785
Views
23
CrossRef citations to date
0
Altmetric
Editorial

Interpreting Results from Clinical Trials: Understanding Minimal Clinically Important Differences in COPD Outcomes

Barry Make Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Medical and Research Center, University of Colorado School of Medicine, Denver, ColoradoUSA; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Medical and Research Center, University of Colorado School of Medicine, 1400 Jackson St., 5211, Denver, Colorado, 80206, USA
, M.D.,
Richard Casaburi Division of Respiratory and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Building RB2, 1124 W Carson Street, Torrance, California, 90502, USA
, Ph.D. , M.D. &
Nancy Kline Leidy MEDTAP International Inc., 7101 Wisconsin Avenue, Suite 600, Bethesda, Maryland, 20814, USA
, R.N. , Ph.D.
Pages 1-5 | Published online: 24 Aug 2009

REFERENCES

  • Rennard S I. Minimally clinically important difference, clinical perspective: an opinion. COPD 2005; 2(1):51–55.
  • Jaeschke R, Singer J, Guyatt G H. Measurement of health status: ascertaining the minimal clincally important difference. Control Clin Trials 1989; 10:407–415. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kiley J P, Sri Ram J, Croxton T L, Weinmann G G. Challenges associated with estimating minimal clinically important differences in COPD—the NHLBI perspective. COPD 2005; 2(1):43–46.
  • Meyer R J. U.S. regulatory perspective on the minimal clinically important difference in chronic obstructive pulmonary disease. COPD 2005; 2(1):47–49.
  • Sutherland E R, Make B J. Maximum exercise as an outcome in COPD: minimal clinically important difference. COPD 2005; 2(1):137–141.
  • Norman G R, Sloan J A, Wyrwich K W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582–592. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sloan J A. Assessing the minimally clinically significant difference:scientific considerations, challenges and solutions. COPD 2005; 2(1):57–62.
  • Norman G R. The relation between the minimally important difference and patient benefit. COPD 2005; 2(1):69–173.
  • Hays R D, Farivar S S, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005; 2(1):63–67.
  • Wyrwich K, Fihn S, Tierney W, Kroenke K, Babu A, Wolinsky F. Clinically important differences in health-related quality of life for patients with Chronic Obstructive Pulmonary Disease: an expert panel report. J Gen Intern Med 2003; 18:196–202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lassere M, van der Hejide D, Johnson K R. Foundations of the minimal clinically important difference for imaging. J Rhematol 2001; 28:890–891. [CSA]
  • Schunemann H J, Puhan M, Goldstein R, Jaeschke R, Guyatt G H. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD 2005; 2(1):81–89. [CSA]
  • Jones P W. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2(1):75–80. [CSA]
  • Donohue J F. Minimal clinically important differences in COPD lung function. COPD 2005; 2(1):111–124. [CSA]
  • Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD 2005; 2(1):131–136. [CSA]
  • Wise R A, Brown C D. Minimal clinically important difference in six-minute walk test and the incremental shuttle walking test. COPD 2005; 2(1):125–129. [CSA]
  • Ries A L. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005; 2(1):105–110. [CSA]
  • Mahler D A, Witek T Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005; 2(1):99–103. [CSA]
  • Leidy N K, Wywich K W. Bridging the gap: using triangulation metholodgy to estimate minimal clinically important differences. COPD 2005; 2(1):157–165. [CSA]
  • Calverley P. Minimal clinically important difference—exacerbations. COPD 2005; 2(1):143–148. [CSA]
  • Wouters E F.M. Minimal clinically important differences in COPD: body mass index and muscle strength. COPD 2005; 2(1):149–155. [CSA]
  • Kaplan R M. The minimally clinically important difference in generic utility-based measures. COPD 2005; 2(1):91–97. [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.